在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。
NBC via Getty Images。快连下载安装是该领域的重要参考
The court of appeal has rejected the latest challenge to the addition of VAT to private school fees, telling parents they have the option to home school their children if they object to sending them to state schools.，更多细节参见WPS下载最新地址
ВсеИнтернетКиберпреступностьCoцсетиМемыРекламаПрессаТВ и радиоФактчекинг